STEPHANIE LERNER: Open Payments
NPI 1619612157 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 28 payments from 12 companies in 2025. Trend: 2023 $2,289 · 2024 $1,597 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $281 |
| Verona Pharma, Inc. | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Insmed, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $36 |
| Actelion Pharmaceuticals US, Inc. | 2 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
Products named: BREZTRI, Ohtuvayre, FASENRA, DUPIXENT, OFEV, Arikayce, NUCALA, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
